Related Experiment Video
Updated: Jan 30, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Prognostic value of left atrial function by cardiovascular magnetic resonance feature tracking in hypertrophic
Rocio Hinojar1,2, Jose Luis Zamorano3,4,5, MªAngeles Fernández-Méndez6
1Cardiology Department, University Hospital Ramón y Cajal, Carretera de Colmenar Km 9.100, 28034, Madrid, Spain. rociohinojar@gmail.com.
Insights
Left atrial longitudinal strain (LA-LS) measured by cardiovascular magnetic resonance myocardial feature tracking (CMR-FT) is impaired in hypertrophic cardiomyopathy (HCM) patients. Reduced LA-LS predicts major adverse cardiovascular outcomes, including mortality and heart failure.
Area of Science:
- Cardiology
- Medical Imaging
Background:
- Left atrial (LA) size and function are crucial for prognosis in hypertrophic cardiomyopathy (HCM).
- Cardiovascular magnetic resonance myocardial feature tracking (CMR-FT) offers novel quantification of LA function.
Purpose of the Study:
- To evaluate LA function using CMR-FT and volumetric analysis in HCM patients.
- To determine the association of LA-longitudinal strain (LA-LS) with major cardiovascular outcomes, including mortality and heart failure.
Main Methods:
- 75 HCM patients and 75 controls underwent conventional CMR with LA function assessment by CMR-FT (LA-LS) and volumetric analysis.
- Primary endpoint: all-cause mortality. Secondary endpoint: heart failure hospital admission, lethal ventricular arrhythmias, or cardiovascular death.
Main Results:
- HCM patients exhibited significantly impaired LA-LS and volumetric LA function compared to controls, even with normal LA volume and LV filling pressures.
- LA-LS correlated with LA-emptying fraction and diastolic function parameters.
- LA-LS was an independent predictor of both primary (all-cause mortality) and secondary composite endpoints during follow-up.
Conclusions:
- CMR-FT provides accurate LA function measurements in HCM.
- LA-LS is a potential novel predictor of adverse cardiovascular outcomes in HCM patients, including mortality and heart failure.
Abstract:
Left atrium (LA) size has an important role in determining prognosis and risk stratification in hypertrophic cardiomyopathy (HCM). Cardiovascular magnetic resonance myocardial feature tracking (CMR-FT) is a novel technique for the quantification of LA function. Our aim was first to evaluate LA function by CMR-FT and volumetric analysis in patients with HCM; and secondly we sought to determine the association of LA-longitudinal strain (LA-LS) with major cardiovascular outcomes, particularly all cause mortality and heart failure. 75 patients with HCM and 75 control subjects underwent a conventional CMR study including assessment of LA function by CMR-FT (LA-LS) and volumetric analysis. A primary endpoint of all-cause mortality and secondary combined endpoint of hospital admission related to heart failure, lethal ventricular arrhythmias or cardiovascular death were defined. Compared to controls, LA-LS and all volumetric indices of LA function were significantly impaired in HCM even in patients with normal LA volume and normal LV filling pressures. LA-LS showed moderate-high correlation with LA-emptying fraction (total, active and passive LA-EF, r = 0.68, r = 0.67, r = 0.31, p < 0.001 for all) and with parameters of diastolic function (E/é, r = 0.4, p < 0.001). The age, minimum LA volume and % of LGE were independent predictors of LA-LS (p < 0.01 for all). During a mean follow-up of 3.3 ± 1.2 years LA-LS was associated with the primary (HR: 0.85 (0.73-0.98), p = 0.02) and the secondary end-point (HR: 0.88 (0.82-0.96), p = 0.003). LA-LS by CMR-FT provides accurate measurements of LA function in HCM patients. LA-LS may become a novel potential predictor of poor cardiac outcomes, particularly cardiovascular mortality and HF.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Magnetic Resonance Imaging
Cardiomyopathy II: Dilated Cardiomyopathy
Atomic Nuclei: Magnetic Resonance
Cardiomyopathy IV: Restrictive Cardiomyopathy
Nuclear Magnetic Resonance (NMR): Overview
NMR spectroscopy generates a spectrum where the characteristic absorption frequencies of the sample are...

